Anticancer Activity, DFT, Molecular Docking, ADMET, and Molecular Dynamics Simulations Investigations of Schiff Base Derived From 2,3‐Diaminophenazine and Its Metal Complexes
- 19 December 2024
- journal article
- research article
- Published by Wiley in Applied Organometallic Chemistry
- Vol. 39 (1)
Abstract
In our previous study, Schiff base (1) complexes derived from 2,3‐diaminophenazine and metal ions Co(II) (2), Ni(II) (3), Cu(II) (4), and Cd(II) (5) were synthesized and characterized, demonstrating a significant biological activity. This study investigates their anticancer potential, specifically against prostate cancer. The complexes exhibited notable reductions in cancer cell viability, with IC50 values of 0.531 μM Ni(II), 0.630 μM Cu(II), and 0.655 μM Co(II), comparable with the standard drug enzalutamide. The Co(II) complex showed the highest efficacy, while Cd(II) displayed the lowest (IC50 = 0.648 μM). The presence of a phenazine ring in these complexes enhances DNA binding, contributing to their anticancer effects. HOMO‐LUMO calculations revealed energy gaps ranging from 2.525 to 3.294 eV, indicating varying reactivity and potential for biological interactions. Molecular docking studies revealed that compound (1) exhibited the highest binding affinity (−9.19 kcal/mol) for the prostate cancer‐related receptor, with significant hydrogen bond interactions. Molecular dynamics simulations over 100 ns demonstrated stable binding, with RMSD values below 1.5 Å, and RMSF analysis provided insights into protein flexibility. ADMET studies revealed favorable drug‐like properties, including good gastrointestinal absorption (> 30%), high blood–brain barrier permeability (LogBBB = 0.64), and high human intestinal absorption (68.47%–88.79%). No inhibition of CYP2D6 was observed, suggesting low risk for drug–drug interactions. These Schiff base‐metal complexes show promising anticancer activity and favorable ADMET profiles, indicating their potential as therapeutic agents for prostate cancer treatment.Keywords
Funding Information
- European Commission
- European Regional Development Fund (GINOP‐2.3.4‐15‐2016‐00004)
This publication has 73 references indexed in Scilit:
- Selective Metal‐Coordinated Nanodrugs Based on Thiazine Moiety for Anticancer Therapeutics: Spectroscopic, Theoretical, and Molecular Docking StudiesApplied Organometallic Chemistry, 2024
- Effect of non-covalent interactions on the stability and structural properties of 2,4-dioxo-4-phenylbutanoic complex: a computational analysisJournal of Molecular Modeling, 2024
- Recent Synthesis of Mono‐ & Bis‐Pyranopyrazole DerivativesChemistrySelect, 2024
- Exploring the antimalarial and antioxidant efficacy of transition metal(II) chelates of thiosemicarbazone ligands: spectral investigations, molecular docking, DFT, MESP and ADMETBioMetals, 2023
- Precise Modulation of Carbon Activity Sites in Metal‐Free Covalent Organic Frameworks for Enhanced Oxygen Reduction ElectrocatalysisSmall, 2023
- Screening of Potential Inhibitors Targeting the Main Protease Structure of SARS-CoV-2 via Molecular Docking, and Approach with Molecular Dynamics, RMSD, RMSF, H-Bond, SASA and MMGBSAMolecular Biotechnology, 2023
- Transition Metal Complexes of (E)‐2((2‐hydroxybenzylidene) amino‐3‐mercaptopropanoic acid: XRD, Anticancer, Molecular modeling and Molecular Docking StudiesChemistrySelect, 2019
- Synthetic routes for phenazines: an overviewResearch on Chemical Intermediates, 2017
- Multiwfn: A multifunctional wavefunction analyzerJournal of Computational Chemistry, 2011
- Synthesis, Characterization and Nuclease Activity of Ternary Copper(II) Complexes Containing Dipyrido[3,2‐a:2′,3′‐c]‐phenazine and L‐α‐Amino AcidsChinese Journal of Chemistry, 2010